Publikationen von Robert Voswinckel

Nikam, V. S.; Nikam, S.; Sydykov, A.; Ahlbrecht, K.; Morty, R. E.; Seeger, W.; Voswinckel, R.: Implication of in vivo circulating fibrocytes ablation in experimental pulmonary hypertension murine model. BRITISH JOURNAL OF PHARMACOLOGY 177 (13), S. 2974 - 2990 (2020)

Giordano, L.; Farnham, A.; Dhandapani, P. K.; Salminen, L.; Bhaskaran, J.; Voswinckel, R.; Rauschkolb, P.; Scheibe, S.; Sommer, N.; Beisswenger, C. et al.; Weissmann, N.; Braun, T.; Jacobs, H. T.; Bals, R.; Herr, C.; Szibor, M.: Alternative Oxidase Attenuates Cigarette Smoke-induced Lung Dysfunction and Tissue Damage. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 60 (5), S. 515 - 522 (2019)

Hempel, F.; Roderfeld, M.; Savai, R.; Sydykov, A.; Irungbam, K.; Schermuly, R.; Voswinckel, R.; Koehler, K.; Churin, Y.; Kiss, L. et al.; Bier, J.; Pons-Kuehnemann, J.; Roeb, E.: Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice. CELLS 8 (10), 1210 (2019)

Ntokou, A.; Szibor, M.; Rodriguez-Castillo, J. A.; Quantius, J.; Herold, S.; El Agha, E.; Bellusci, S.; Salwig, I.; Braun, T.; Voswinckel, R. et al.; Seeger, W.; Morty, R. E.; Ahlbrecht, K.: A novel mouse Cre-driver line targeting Perilipin 2-expressing cells in the neonatal lung. GENESIS 55 (12), e23080 (2017)